What decline in pain intensity is meaningful to patients with acute pain?
暂无分享,去创建一个
[1] S. Hassenbusch,et al. Management of cancer pain. , 2001, Evidence report/technology assessment.
[2] J. Lau,et al. Management of cancer symptoms: pain, depression, and fatigue. , 2002, Evidence report/technology assessment.
[3] D. Carr,et al. The combination of low dose of naloxone and morphine in PCA does not decrease opioid requirements in the postoperative period , 2002, Pain.
[4] C A Bodian,et al. The Visual Analog Scale for Pain: Clinical Significance in Postoperative Patients , 2001, Anesthesiology.
[5] J. Farrar,et al. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale , 2001, PAIN.
[6] A. Kelly,et al. Determining the minimum clinically significant difference in visual analog pain score for children. , 2001, Annals of emergency medicine.
[7] Jesse A. Berlin,et al. Defining the clinically important difference in pain outcome measures , 2000, PAIN.
[8] J. Riley,et al. A meta-analytic review of pain perception across the menstrual cycle , 1999, Pain.
[9] A. Woodhouse,et al. Intra-subject variability in post-operative patient-controlled analgesia (PCA): is the patient equally satisfied with morphine, pethidine and fentanyl? , 1999, Pain.
[10] M. Good. Acute Pain , 1999, Annual Review of Nursing Research.
[11] G. Wells,et al. Should improvement in rheumatoid arthritis clinical trials be defined as fifty percent or seventy percent improvement in core set measures, rather than twenty percent? , 1998, Arthritis and rheumatism.
[12] S. Follin,et al. Acute Pain Management: Operative or Medical Procedures and Trauma , 1997, The Annals of pharmacotherapy.
[13] H. McQuay,et al. The visual analogue pain intensity scale: what is moderate pain in millimetres? , 1997, PAIN.
[14] David Gavaghan,et al. Deriving dichotomous outcome measures from continuous data in randomised controlled trials of analgesics: use of pain intensity and visual analogue scales , 1997, Pain.
[15] D. Gavaghan,et al. Deriving dichotomous outcome measures from continuous data in randomised controlled trials of analgesics: verification from independent data , 1997, Pain.
[16] M. Homma. [ACR preliminary definition, of improvement in rheumatoid arthritis]. , 1996, Ryumachi. [Rheumatism].
[17] D. Gavaghan,et al. Deriving dichotomous outcome measures from continuous data in randomised controlled trials of analgesics , 1996, PAIN®.
[18] J. Levine,et al. Gender difference in analgesic response to the kappa-opioid pentazocine , 1996, Neuroscience Letters.
[19] J J Anderson,et al. American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. , 1995, Arthritis and rheumatism.
[20] Katherine R. Edwards,et al. When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function , 1995, Pain.
[21] Kathleen M. Moran. Acute Pain Management: Operative or Medical Procedures and Trauma. Clinical Practice Guideline. , 1993 .
[22] E. Laska,et al. The Design of Analgesic Clinical Trials , 1991, Annals of Internal Medicine.
[23] G. Guyatt,et al. Measurement of health status. Ascertaining the minimal clinically important difference. , 1989, Controlled clinical trials.
[24] P. Albert,et al. Models for longitudinal data: a generalized estimating equation approach. , 1988, Biometrics.
[25] Donald D. Price,et al. A simultaneous comparison of Fentanyl's analgesic effects on experimental and clinical pain , 1986, Pain.
[26] D. Price,et al. A psychophysical analysis of morphine analgesia , 1985, Pain.
[27] J. Bonica,et al. Management of cancer pain. , 1984, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[28] H. White. Maximum Likelihood Estimation of Misspecified Models , 1982 .
[29] D. Kleinbaum,et al. Applied Regression Analysis and Other Multivariate Methods , 1978 .
[30] Shipman Jj. PREVENTION OF THROMBOSIS. , 1964 .
[31] L. Lasagna. The psychophysics of clinical pain. , 1962, Lancet.